Viewing StudyNCT03049449



Ignite Creation Date: 2024-05-06 @ 9:41 AM
Last Modification Date: 2024-10-26 @ 12:18 PM
Study NCT ID: NCT03049449
Status: COMPLETED
Last Update Posted: 2023-01-18
First Post: 2017-02-09

Brief Title: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Lymphoma T-Cell Peripheral
Lymphoma Large-Cell Anaplastic
Enteropathy-Associated T-Cell Lymphoma
Lymphoma Large B-Cell Diffuse
Lymphoma Extranodal NK-T-Cell
Keywords:
Name View
Angioimmunoblastic T-cell lymphoma View
Gray Zone Lymphoma View
Immunotherapy View
Peripheral T-Cell Lymphoma View
Anaplastic Large Cell Lymphoma View